Delos Reyes, Mark Harvey M.
HRN: 22-35-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2022
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
12/28/2022
01/03/2023
ORAL
2.5ml
Q12Hrs
PCAP-C
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes